Sung Jin Lee

Dr. Sung Jin Lee


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2025 in Cancers
Verified
Journal Article
Open access
PDF file
HKHyun Il Kim
Hyun Il Kim
DJDa Hyun Jung
Da Hyun Jung
SLSung Jin Lee
Sung Jin Lee
NKNamo Kim
Namo Kim
SKSeung Hyun Kim
Seung Hyun Kim
SSSung Kwan Shin
Sung Kwan Shin
Background: Patients undergoing endoscopic submucosal dissection under monitored anesthesia care (MAC) with remimazolam may develop respiratory distress during the procedure. In these cases, low doses of flumazenil improved respiratory distress without completely reversing sedation, which is a novel phenomenon. This study aimed to explore the ED90 of flumazenil to selectively improve respiratory distress in patients with MAC treated with remimazolam. Methods: Flumazenil dose determination followed a biased-coin up-and-down design. Starting with a dose of 5 mcg, if respiratory distress improved, the biased-coin method was used to give the same dose in the next patient with a probability of 8/9, and a decreased dose of 5 mcg in the next patient with a probability of 1/9. Any improvement in respiratory distress within 30 s of flumazenil administration was recorded. After the procedure, patients were asked whether they had any memory recall during the procedure. Centered isotonic regression was used to determine the ED90 of flumazenil. Results: Sixty patients were included in the study. The estimated ED90 was 76.72 mcg (95% CI: 68.07–102.62). Memory recall occurred in two of thirteen patients (15%) near the ED90 dose range (75 mcg and 80 mcg). None of the patients developed major postoperative complications (bleeding, perforation, or aspiration) within the 2-day postoperative period. Conclusions: This study determined that the ED90 of flumazenil for effectively alleviating respiratory distress in patients undergoing MAC with remimazolam was 76.7 mcg, without reversing consciousness. These findings provide valuable guidance for the care of patients undergoing sedation.

Verified
Journal Article
Open access
PDF file
HKHyun Il Kim
Hyun Il Kim
DJDa Hyun Jung
Da Hyun Jung
SLSung Jin Lee
Sung Jin Lee
YLYong Chan Lee
Yong Chan Lee
Sang Kil LeeSang Kil Lee
Sang Kil Lee
SSSung Kwan Shin
Sung Kwan Shin
Background and study aims: Endoscopic submucosal dissection is used to treat early gastric neoplasms. Compared with other endoscopic procedures, it requires higher doses of opioids, leading to adverse events during monitored anesthesia care. We investigated the correlations between clinicopathological characteristics and intraprocedural opioid requirements in patients who underwent endoscopic submucosal dissection under monitored anesthesia care. Patients and methods: The medical records of patients who underwent endoscopic submucosal dissection under monitored anesthesia care were retrospectively reviewed. The dependent variable was the total dose of fentanyl administered during the dissection, while independent variables were patient demographics, the American Society of Anesthesiologists physical status classification, preoperative vital sign data, and the pathological characteristics of the neoplasm. Correlations between variables were examined using multiple regression analysis. Results: The study included 743 patients. The median total fentanyl dose was 100 mcg. Younger age (coefficient −1.37; 95% confidence interval [CI] −1.78 to −0.95), male sex (16.12; 95% CI 6.99–25.24), baseline diastolic blood pressure (0.44; 95% CI 0.04–0.85), neoplasm length (1.63; 95% CI 0.90–2.36), and fibrosis (28.59; 95% CI 17.77–39.42) were positively correlated with the total fentanyl dose. Total fentanyl dose was higher in the differentiated (16.37; 95% CI 6.40–26.35) and undifferentiated cancers group (32.53; 95% CI 16.95–48.11) than in the dysplasia group; no significant differences were observed among the others. The mid-anterior wall (22.69; 95% CI 1.25–44.13), mid-posterior wall (29.65; 95% CI 14.39–44.91), mid-greater curvature (28.77; 95% CI 8.56–48.98), and upper groups (30.06; 95% CI 5.01–55.12) had higher total fentanyl doses than the lower group, whereas doses did not significantly differ for the mid-lesser curvature group. Conclusions: We identified variables that influenced opioid requirements during monitored anesthesia care for endoscopic submucosal dissection. These may help predict the needed opioid doses and identify factors affecting intraprocedural opioid requirements.